# Cardiovascular Effects of COVID-19

> **NCT04365699** · PHASE2 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 81 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** AT-001

## Key facts

- **NCT ID:** NCT04365699
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-08
- **Primary completion:** 2021-01-31
- **Final completion:** 2021-01-31
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04365699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04365699, "Cardiovascular Effects of COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04365699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*